Stocks attracting fund managers in June 2020
Stocks attracting fund managers in June 2020

Stocks attracting fund managers in June 2020

Henil Shah Article rating: 4.0

Everyone is eager to know what the mutual fund managers bought and sold but mostly keen to know what they bought. So, let us know more about the stocks that attracted fund managers in June 2020.

FPO analysis: Yes Bank
FPO analysis: Yes Bank

FPO analysis: Yes Bank

Shashikant Singh Article rating: 3.4

India’s sixth-largest private sector bank on the basis of the total standalone assets as on March 31, 2019, is coming out with its further public offering. Read on to find out why you should subscribe to this issue.

FDC surge over 8 per cent; forms bullish opening Marubozu candle
FDC surge over 8 per cent; forms bullish opening Marubozu candle

FDC surge over 8 per cent; forms bullish opening Marubozu candle

Vinayak Gangule Article rating: 4.3

Considering the daily timeframe, the stock of FDC Limited has formed a bullish opening Marubozu candle near the upward sloping trendline support, which coincides with the 100-day EMA level. This suggests that the bulls are taking control near the medium-term support.

Vaishali Pharma launches Vitamin C supplements to boost immunity
Vaishali Pharma launches Vitamin C supplements to boost immunity

Vaishali Pharma launches Vitamin C supplements to boost immunity

Apurva Joshi Article rating: 3.4

Vaishali Pharma Limited has launched Vipravita C (Vitamin C supplements) for domestic as well as international market to boost immunity against various prevailing diseases. These supplements are available in different variants like Vitamin C chewable tablets, Vitamin C effervescent tablets and Vitamin C with zinc combo.

Cipla gets USFDA nod for Icatibant Injectable
Cipla gets USFDA nod for Icatibant Injectable

Cipla gets USFDA nod for Icatibant Injectable

Anthony Fernandes Article rating: 5.0

On Tuesday, pharma major Cipla Limited declared that it has been granted approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL by United States Food and Drug Administration (USFDA).

City Union Bank to raise Rs 1,100 crore
City Union Bank to raise Rs 1,100 crore

City Union Bank to raise Rs 1,100 crore

Nidhi Jani Article rating: 5.0

At the end of FY20, the bank reported its Tier I capital adequacy ratio at 15.80 per cent, well above the regulatory requirement. These fundraising plans add additional strength to its core fundamentals. The CASA ratio at 25 per cent (Rs 1,000 crore) along with debt funds can be expected to maintain a low cost of borrowing.

Fitch Ratings believe near-term recovery not probable for NBFCs
Fitch Ratings believe near-term recovery not probable for NBFCs

Fitch Ratings believe near-term recovery not probable for NBFCs

Amir Shaikh Article rating: 4.6

The rating agency Fitch in its latest report said that a near-term recovery for India's non-banking financial institutions is not probable, as the sector continues to wrestle with the fallout of Coronavirus pandemic

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.5

The market opened in the red on July 14, 2020, overall volumes in futures & options currently stand at 1,88,70,614 crore contracts with a turnover of Rs. 11,67,812.51 crore.

RSS
First20772078207920802082208420852086Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR